Personalized multidisciplinary decision-making for mastectomy type and breast reconstruction in triple-negative breast cancer: a single-center retrospective cohort study and a proposed three-level oncological–reconstructive–supportive framework

Background Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype and disproportionately affects younger, premenopausal, and BRCA -mutation-carrying women, placing many patients at the intersection of oncology and reproductive medicine. Integration of reconstruction, psychosocial care, and fertility-preservation counseling into the TNBC surgical pathway remains heterogeneous, particularly in Eastern Europe. We aimed to characterize pathological response, surgical patterns, and the documentation of multidisciplinary care in TNBC at a Romanian tertiary center, and to propose a decision framework for prospective evaluation. Methods We retrospectively analyzed the 22 consecutive TNBC patients among 420 patients operated on for breast cancer between 2020 and 2025, using institutional database records only. Data were analyzed descriptively with Wilson 95% confidence intervals (CIs); mastectomy type among TNBC mastectomies (n = 10) was compared descriptively with that among non-TNBC mastectomies (n = 176). Observed practice was mapped against published evidence to construct a three-level decision framework. Results All patients received neoadjuvant chemotherapy; pathological complete response (pCR, ypT0/is ypN0) occurred in 7 of 22 (31.8%; Wilson 95% CI 16.4–52.7); subgroups were too small to interpret. Of 15 patients with residual disease, 8 (53.3%) had lymphatic, vascular, or perineural invasion, 6 (40.0%) residual ypT2 disease, and 3 (20.0%) nodal involvement. All 10 TNBC mastectomies were recorded as simple mastectomies, although 4 of these patients had achieved pCR; none was recorded as skin-sparing (0 of 10, 0.0%; Wilson 95% CI 0.0–27.8), versus 7 of 176 non-TNBC mastectomies (4.0%; Wilson 95% CI 1.9–8.0), and the groups were too small for formal testing. The database contained no field for reconstruction, plastic-surgery consultation, psychosocial screening, fertility-preservation referral, germline BRCA testing, or palliative assessment. Conclusions In this cohort, no skin-sparing mastectomy was recorded after neoadjuvant chemotherapy, even after pCR, and the reconstructive, psychosocial, reproductive, and palliative dimensions of care were not captured in the surgical database. These are documentation gaps; whether the corresponding care was provided cannot be determined. We propose a three-level oncological–reconstructive–supportive (O-R-S) framework, anchored at three tumor-board time points with auditable process indicators, to make surgical decisions in TNBC explicit and documented, as a protocol for prospective validation.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2026-11-20
DOI
https://doi.org/10.3389/fonc.2026.2011075
Primary Topic
Breast Cancer Treatment Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Personalized multidisciplinary decision-making for mastectomy type and breast reconstruction in triple-negative breast cancer: a single-center retrospective cohort study and a proposed three-level oncological–reconstructive–supportive framework

Vladimir Poroch, Mihaela Perţea, Maria Gabriela AniŢei, Iulian Radu et al.
1 links
Frontiers in Oncology
Breast Cancer Treatment Studies
article

Personalized multidisciplinary decision-making for mastectomy type and breast reconstruction in triple-negative breast cancer: a single-center retrospective cohort study and a proposed three-level oncological–reconstructive–supportive framework

Vladimir Poroch, Mihaela Perţea, Maria Gabriela AniŢei, Iulian Radu, Alexandra Lazan, Marcel-Alexandru Gaina, Theodor Florin Pantilimonescu, Dan Cristian Moraru, Simona Ruxandra Volovat, Marius Valeriu Hinganu
article en

Abstract

Background Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype and disproportionately affects younger, premenopausal, and BRCA -mutation-carrying women, placing many patients at the intersection of oncology and reproductive medicine. Integration of reconstruction, psychosocial care, and fertility-preservation counseling into the TNBC surgical pathway remains heterogeneous, particularly in Eastern Europe. We aimed to characterize pathological response, surgical patterns, and the documentation of multidisciplinary care in TNBC at a Romanian tertiary center, and to propose a decision framework for prospective evaluation. Methods We retrospectively analyzed the 22 consecutive TNBC patients among 420 patients operated on for breast cancer between 2020 and 2025, using institutional database records only. Data were analyzed descriptively with Wilson 95% confidence intervals (CIs); mastectomy type among TNBC mastectomies (n = 10) was compared descriptively with that among non-TNBC mastectomies (n = 176). Observed practice was mapped against published evidence to construct a three-level decision framework. Results All patients received neoadjuvant chemotherapy; pathological complete response (pCR, ypT0/is ypN0) occurred in 7 of 22 (31.8%; Wilson 95% CI 16.4–52.7); subgroups were too small to interpret. Of 15 patients with residual disease, 8 (53.3%) had lymphatic, vascular, or perineural invasion, 6 (40.0%) residual ypT2 disease, and 3 (20.0%) nodal involvement. All 10 TNBC mastectomies were recorded as simple mastectomies, although 4 of these patients had achieved pCR; none was recorded as skin-sparing (0 of 10, 0.0%; Wilson 95% CI 0.0–27.8), versus 7 of 176 non-TNBC mastectomies (4.0%; Wilson 95% CI 1.9–8.0), and the groups were too small for formal testing. The database contained no field for reconstruction, plastic-surgery consultation, psychosocial screening, fertility-preservation referral, germline BRCA testing, or palliative assessment. Conclusions In this cohort, no skin-sparing mastectomy was recorded after neoadjuvant chemotherapy, even after pCR, and the reconstructive, psychosocial, reproductive, and palliative dimensions of care were not captured in the surgical database. These are documentation gaps; whether the corresponding care was provided cannot be determined. We propose a three-level oncological–reconstructive–supportive (O-R-S) framework, anchored at three tumor-board time points with auditable process indicators, to make surgical decisions in TNBC explicit and documented, as a protocol for prospective validation.

Frontiers in OncologyVol. 16
Grigore T. Popa University of Medicine and Pharmacy (RO), Institutul Regional de Oncologie (RO), Spitalul Clinic Dr. C. I. Parhon (RO), Spitalul Clinic Judeţean de Urgenţe "Sf. Spiridon" Iaşi (RO)
Good health and well-being
Breast Cancer Treatment Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon